TKNO teknova.com: Company Value to Revenue

A steady inflow of funds from the sale of biopharma reagents creates a reliable foundation for Alpha Teknova, Inc. (TKNO). On GURU.Markets, the historical EV/Sales level confirms this momentum, with the current value equal to 10918.61. Recurring purchases of consumables maintain operational momentum, although global raw material logistics disruptions and sanctions may temporarily limit the company's export of biological media.
TKNO (Teknova Inc): analytical breakdowns and indicator data

Alpha Teknova, Inc. (TKNO) maintains stabilized cash flows due to its broad client diversification within the biopharmaceutical sector. An analysis of the enterprise value-to-revenue multiple allows for an assessment of the business's market value excluding debt load. This metric compares the total enterprise value to sales volume, revealing the actual efficiency of capitalization. This chart helps determine if the asset is overbought relative to revenue growth rates, which is critical for preventing capital freeze during periods of inflated market expectations.